Your browser is no longer supported. Please, upgrade your browser.
Settings
ADMP Adamis Pharmaceuticals Corporation daily Stock Chart
ADMP [NASD]
Adamis Pharmaceuticals Corporation
Index- P/E- EPS (ttm)-1.53 Insider Own17.22% Shs Outstand21.58M Perf Week-5.62%
Market Cap90.64M Forward P/E- EPS next Y-0.73 Insider Trans0.00% Shs Float18.12M Perf Month23.53%
Income-23.80M PEG- EPS next Q-0.23 Inst Own20.60% Short Float14.18% Perf Quarter50.00%
Sales4.00M P/S22.66 EPS this Y-15.50% Inst Trans-2.07% Short Ratio7.64 Perf Half Y26.89%
Book/sh1.26 P/B3.33 EPS next Y50.70% ROA-104.70% Target Price7.50 Perf Year-29.77%
Cash/sh0.36 P/C11.62 EPS next 5Y- ROE-164.50% 52W Range2.40 - 10.98 Perf YTD33.33%
Dividend- P/FCF- EPS past 5Y11.30% ROI- 52W High-61.75% Beta-0.53
Dividend %- Quick Ratio1.10 Sales past 5Y- Gross Margin20.90% 52W Low75.00% ATR0.29
Employees15 Current Ratio1.20 Sales Q/Q- Oper. Margin- RSI (14)56.53 Volatility8.34% 6.92%
OptionableYes Debt/Eq0.31 EPS Q/Q-74.30% Profit Margin- Rel Volume0.98 Prev Close4.45
ShortableYes LT Debt/Eq0.13 EarningsMar 29 Payout- Avg Volume336.13K Price4.20
Recom2.00 SMA204.32% SMA5018.33% SMA20035.64% Volume329,950 Change-5.62%
Jul-21-16Reiterated Maxim Group Buy $17 → $10
Dec-01-15Initiated Maxim Group Buy $16
May-29-15Initiated Mizuho Buy $10
Jan-28-14Initiated CRT Capital Buy $15
Mar-08-17 08:15AM  Adamis (ADMP) Shows Strength: Stock Gains 6.7% in Session +7.50%
Mar-07-17 08:48AM  Adamis Pharmaceuticals (ADMP) Shares March Higher, Can It Continue? +6.67%
Mar-03-17 10:10AM  Sio Capital Remains Bullish On These Stocks Despite Weak Performance at Insider Monkey
Feb-27-17 08:49AM  Is the Options Market Predicting a Spike in Adamis Pharmaceuticals (ADMP) Stock?
Jan-23-17 11:03AM  [$$] Why Adamis Tops Impax Syringe at CVS Health at Barrons.com
Jan-19-17 09:00AM  Adamis Pharmaceuticals Announces FDA Acceptance of Resubmission of Its Epinephrine Pre-Filled Syringe NDA GlobeNewswire
Jan-11-17 06:08AM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
Dec-23-16 04:28PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Other Events +5.56%
Dec-22-16 01:10PM  These 5 Stocks Under $10 Could Make You a Lot of Money
Dec-16-16 11:10PM  [$$] Mylan Launches Cheaper Generic EpiPen Alternative at The Wall Street Journal
09:00AM  Adamis Pharmaceuticals Announces NDA Resubmission of Its Epinephrine Pre-Filled Syringe Application to the FDA GlobeNewswire
Dec-15-16 08:57AM  Is VOXX International Corp (VOXX) A Good Stock To Buy? at Insider Monkey
Nov-19-16 01:04PM  ADAMIS PHARMACEUTICALS CORP Financials
Nov-14-16 05:54PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report
Sep-23-16 04:16PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Financial Statements and Exhibits
Sep-02-16 03:11PM  Relief From EpiPen's Stranglehold May Come From Rivals Before Politicians
08:23AM  Mylans EpiPen caught the full force of drug price outrage because it was the perfect target, not because it was the only one at MarketWatch
Aug-30-16 12:07AM  [$$] Mylans New Generic Causes Stock-Market Ripple at The Wall Street Journal
Aug-29-16 03:49PM  Here's a Reason Why Adamis Pharmaceuticals (ADMP) Stock Is Slumping Today -14.41%
11:15AM  Mylan's New Generic Causes Stock Market Ripple at The Wall Street Journal
10:10AM  8 Top Movers and Hot Stocks for Monday at 24/7 Wall St.
Aug-26-16 02:01PM  Pharmacy Benefit Managers Shouldn't Fret Initial Fallout from Mylan Fiasco +25.27%
11:36AM  Here's a Reason Why Adamis Pharmaceuticals (ADMP) Stock Is Soaring Today
07:56AM  [$$] Mylan's EpiPen Fallout Benefits Adamis at Barrons.com
Aug-25-16 11:07AM  Mylan Is Done Leaning on EpiPen Sales and That Could be a Big Problem
Aug-23-16 12:02PM  A Backlash Materializes Against Soaring EpiPen Prices +9.29%
Aug-18-16 11:55AM  5 Breakout Stocks Under $10 Set to Soar
Aug-16-16 06:19AM  Adamis reports 2Q loss
Aug-15-16 05:26PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report
Aug-03-16 09:00AM  Adamis Pharmaceuticals Strengthens Patent Portfolio for its Dry Powder Inhaler GlobeNewswire
Jul-29-16 05:27PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial S -5.70%
08:45AM  Adamis Pharmaceuticals Announces $11.1 Million Registered Direct Offering GlobeNewswire
Jul-28-16 06:09AM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jul-21-16 09:00AM  Adamis Pharmaceuticals Provides Update On License Agreement with Allergan plc GlobeNewswire
Jul-12-16 09:01AM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equi
09:00AM  Adamis Pharmaceuticals Announces Private Placement GlobeNewswire
Jun-27-16 04:54PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K/A, Financial Statements and Exhibits
Jun-13-16 05:08PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Other Events
Jun-12-16 10:20AM  7 Biopharma Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Jun-07-16 12:11AM  [$$] Overheard: Mylan Shares Rise at The Wall Street Journal -6.60%
Jun-06-16 07:46PM  [$$] Overheard at The Wall Street Journal -53.84%
01:48PM  Stocks gain traction as Yellen plays down weak jobs report at MarketWatch
01:08PM  Mylan Gains From Adamis Pain at The Wall Street Journal
12:37PM  Why Adamis Pharmaceuticals, Immunomedics and Three Other Stocks Are Deep in Red Today? at Insider Monkey
11:50AM  Why is Adamis Pharmaceuticals (ADMP) Stock Crashing Today?
11:40AM  The 5 Biggest Biotech and Pharma Losers From ASCO at 24/7 Wall St.
11:16AM  Adamis Pharmaceuticals Story is Delayed Another 12 to 18 Months Still A Buy at Insider Monkey
10:19AM  Adamis Pharmaceuticals (ADMP) Stock Plummeting on FDA Drug Rejection
09:31AM  Stocks to Watch: Adamis Pharmaceuticals, Ocular Therapeutix, ProNAi Therapeutics at The Wall Street Journal
09:24AM  Walmart upgraded, Whole Foods gets the Barrons bump
07:55AM  Wall Street turns to Yellen after dismal jobs report
07:44AM  FDA rejects Adamis' emergency drug for severe allergic reaction Reuters
07:26AM  FDA Advises Adamis Pharmaceuticals To Expand Human Factors And Reliability To Support Its NDA For Epinephrine Injection
07:10AM  FDA rejects Adamis' emergency treatment for severe allergic reaction Reuters
07:00AM  Adamis's stock plunges after FDA requires more tests for NDA product at MarketWatch
06:45AM  Adamis Pharmaceuticals Receives Complete Response Letter From FDA For Its Epinephrine Pre-Filled Syringe NDA GlobeNewswire
May-31-16 05:05PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-13-16 04:34PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report
May-10-16 04:28PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events -11.17%
06:45AM  Adamis Pharmaceuticals Announces License Agreement with Allergan plc Subsidiary for Epinephrine Pre-Filled Syringe GlobeNewswire
May-09-16 04:54PM  Why Is Adamis Pharmaceuticals Corporation (ADMP) So Hot Right Now? at Insider Monkey +12.20%
Apr-12-16 07:01AM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition +6.16%
06:45AM  Adamis Pharmaceuticals Completes Acquisition of US Compounding GlobeNewswire
Mar-29-16 07:17AM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fina +9.84%
07:03AM  Adamis Pharmaceuticals Announces Agreement to Acquire US Compounding at noodls
06:45AM  Adamis Pharmaceuticals Announces Agreement to Acquire US Compounding GlobeNewswire
Mar-23-16 04:14PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 10-K, Annual Report
Mar-14-16 05:33PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
Jan-29-16 04:15PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pr
Jan-26-16 05:23PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equi
04:32PM  Adamis Pharmaceuticals Announces Private Placement at noodls
04:05PM  Adamis Pharmaceuticals Announces Private Placement GlobeNewswire
Jan-14-16 04:05PM  Adamis Pharmaceuticals Announces FDA Acceptance of Resubmission of Its Epinephrine Pre-Filled Syringe NDA GlobeNewswire
Dec-31-15 04:31PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pr
Dec-07-15 09:00AM  Adamis Pharmaceuticals Announces NDA Resubmission of Its Epinephrine Pre-Filled Syringe Application to the FDA GlobeNewswire
Nov-09-15 02:03PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report -6.02%
Oct-07-15 09:35AM  Does Smart Money Share This Retiring Hedge Fund Managers Views on 5 Long-Term Bets? at Insider Monkey
Aug-09-15 08:13PM  10-Q for Adamis Pharmaceuticals Corp. at Company Spotlight
Aug-07-15 06:08PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report -5.29%
Aug-06-15 09:00AM  Adamis Pharmaceuticals Provides Regulatory Update on Its Epinephrine Pre-Filled Syringe GlobeNewswire -6.15%
May-29-15 06:54AM  Coverage initiated on Adamis Pharma by Mizuho
May-28-15 09:56AM  Biotech investors up big amid bubble talk at CNBC
May-19-15 03:48PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-16-15 08:09PM  10-Q for Adamis Pharmaceuticals Corp. at Company Spotlight
May-14-15 04:42PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report
Apr-16-15 09:00AM  Adamis Pharmaceuticals Announces Positive Clinical Study Results for Its Albuterol (Salbutamol) HFA Product GlobeNewswire +6.03%
Apr-15-15 09:00AM  Adamis Pharmaceuticals Announces Key Additions to Its Commercial Sales Team GlobeNewswire
Apr-03-15 06:47PM  Lifshitz & Miller Law Firm Announces Investigation of Accelerate Diagnostics, Inc., Adamis Pharmaceuticals Corporation, Aerohive Networks, Inc., Boulder Brands, Inc., Dynamic Materials Corporation and SanDisk Corp. PR Newswire
Apr-02-15 10:30AM  Investors with Losses in Excess of $100,000 in ADMP Stock: Investigation of Adamis Pharmaceuticals Corporation Announced by The Law Offices of Howard G. Smith Business Wire
Mar-30-15 04:01PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Adamis Pharmaceuticals Corporation PR Newswire -28.94%
10:38AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamis Pharmaceuticals Corporation - ADMP PR Newswire
06:07AM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Mar-27-15 05:41PM  Adamis Pharmaceuticals Receives Complete Response Letter From FDA for Its Epinephrine Pre-Filled Syringe NDA GlobeNewswire
Mar-11-15 04:47PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
Mar-03-15 09:00AM  Adamis Pharmaceuticals Announces Positive Pharmacokinetic Study Results For Its Dry Powder Inhaler Product GlobeNewswire
Feb-24-15 09:00AM  Adamis Pharmaceuticals Announces Positive Pharmacokinetic Study Results for Its Beclomethasone Dipropionate HFA Product GlobeNewswire
Feb-21-15 04:17PM  Stocks From Leading Industries
Jan-28-15 09:00AM  Adamis Pharmaceuticals Receives Notice of Allowance for US and Japanese Patents for Its Dry Powder Inhaler GlobeNewswire
Jan-14-15 10:20AM  Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full GlobeNewswire
Jan-09-15 12:29PM  ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial S
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, engages in developing and commercializing products in the therapeutic areas of allergy and respiratory disease. Its specialty pharmaceutical product candidates include the Epinephrine Injection PFS syringe product for use in the emergency treatment of anaphylaxis; APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease; and APC-2000 for the treatment of bronchospasms. The company also has various biotechnology product candidates and technologies, including therapeutic vaccine and cancer product candidates that comprise TeloB-VAX (vaccine), APC-100, APC-200, and APC-300, which are under development for the treatment of prostate cancer. In addition, it operates a 503B drug outsourcing facility that provides prescription medications to patients, physician clinics, hospitals, and surgery centers in the United States. The company is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Marguglio David J.SR. VP of Corporate Devel.Jun 02Sale9.007006,301101,527Jun 06 04:11 PM
Marguglio David J.SR VP OF CORPORATE DEVELOPMENTMay 16Sale8.084,00032,339102,227May 18 06:57 PM
Marguglio David J.SR VP of Corporate DevelopmentMay 09Sale10.004,86048,600106,227May 11 04:32 PM
Marguglio David J.SR VP of Corporate DevelopmentMay 04Sale9.174,86044,577112,227May 06 04:47 PM
Marguglio David J.SR VP of Corporate DevelopmentMay 03Sale9.001,14010,260117,087May 05 05:18 PM
Marguglio David J.SR VP of Corporate DevelopmentApr 14Sale7.5212,00090,216118,227Apr 18 05:27 PM